{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:03Z","timestamp":1791357363805,"version":"4.3.1"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11481-011-9288-1","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T16:02:33Z","timestamp":1309795353000},"page":"113-139","source":"Crossref","is-referenced-by-count":212,"title":["Methamphetamine-Associated Psychosis"],"prefix":"10.1007","volume":"7","author":[{"given":"Kathleen M.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia D.","family":"LeVan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott F.","family":"Stoltenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick A.","family":"Bevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,5]]},"reference":[{"key":"9288_CR1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2007.12.488","volume":"101","author":"T Abekawa","year":"2008","unstructured":"Abekawa T, Ito K, Nakagawa S, Nakato Y, Koyama T (2008) Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex. Schizophr Res 101:84\u201394","journal-title":"Schizophr Res"},{"key":"9288_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1196\/annals.1369.012","volume":"1074","author":"K Akiyama","year":"2006","unstructured":"Akiyama K (2006) Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence. Ann New York Acad Sci 1074:125\u2013134","journal-title":"Ann New York Acad Sci"},{"key":"9288_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1749-6632.1996.tb17437.x","volume":"801","author":"T Amano","year":"1996","unstructured":"Amano T, Matsubayashi H, Sasa M (1996) Hypersensitivity of nucleus accumbens neurons to methamphetamine and dopamine following repeated administrations of methamphetamine. Ann N Y Acad Sci 801:136\u2013147","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3940(03)00673-6","volume":"347","author":"T Amano","year":"2003","unstructured":"Amano T, Matsubayashi H, Seki T, Sasa M, Sakai N (2003) Repeated administration of methamphetamine causes hypersensitivity of D2 receptor in rat ventral tegmental area. Neurosci Lett 347:89\u201392","journal-title":"Neurosci Lett"},{"key":"9288_CR5","first-page":"387","volume-title":"Amphetamine and its analogues","author":"B Angrist","year":"1994","unstructured":"Angrist B (1994) Amphetamine psychosis: clinical variations of the syndrome. In: Cho A, Segal D (eds) Amphetamine and its analogues. Academic, San Diego, pp 387\u2013414"},{"key":"9288_CR6","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1530-0277.2006.00215.x","volume":"30","author":"N Aoyama","year":"2006","unstructured":"Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N et al (2006) Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcohol Clin Exp Res 30:1644\u20131649","journal-title":"Alcohol Clin Exp Res"},{"key":"9288_CR7","volume-title":"Diagnostic and statistical manual of mental disorders","author":"APA American Psychiatric Association","year":"2000","unstructured":"APA American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington","edition":"4"},{"key":"9288_CR8","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/npp.2008.41","volume":"33","author":"S Arai","year":"2008","unstructured":"Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Takshashi K et al (2008) Involvement of pallidotegmental neurons in methamphetamine- and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen. Neuropsychopharmacology 33:3164\u20133175","journal-title":"Neuropsychopharmacology"},{"key":"9288_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2008.10.065","volume":"602","author":"S Arai","year":"2009","unstructured":"Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Kamei H et al (2009) GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice. Eur J Pharmacol 602:101\u2013104","journal-title":"Eur J Pharmacol"},{"key":"9288_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0031-9384(94)90098-1","volume":"55","author":"O Arakawa","year":"1994","unstructured":"Arakawa O (1994) Effects of methamphetamine and methylphenidate on single and paired rat open-field behavior. Physiol Behav 55:441\u2013446","journal-title":"Physiol Behav"},{"key":"9288_CR11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","volume":"184","author":"L Arseneault","year":"2004","unstructured":"Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110\u2013117","journal-title":"Br J Psychiatry"},{"key":"9288_CR12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.mp.4001012","volume":"7","author":"JA Badner","year":"2002","unstructured":"Badner JA, Gershon ES (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7:405\u2013411","journal-title":"Mol Psychiatry"},{"key":"9288_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00427514","volume":"64","author":"JJ Balsara","year":"1979","unstructured":"Balsara JJ, Jadhav JH, Muley MP, Chandorkar AG (1979) Effects of drugs influencing central serotonergic mechanisms on methamphetamine stereotyped behavior in the rat. Psychopharmacology 64:303\u2013307","journal-title":"Psychopharmacology"},{"key":"9288_CR14","volume-title":"The rat: a study in behaviour","author":"SA Barnett","year":"1963","unstructured":"Barnett SA (1963) The rat: a study in behaviour. Aldine, Chicago"},{"key":"9288_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10550490490512834","volume":"13","author":"SL Batki","year":"2004","unstructured":"Batki SL, Harris DS (2004) Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesias. Am J Addict 13:461\u2013470","journal-title":"Am J Addict"},{"key":"9288_CR16","doi-asserted-by":"crossref","first-page":"24232","DOI":"10.1074\/jbc.M010418200","volume":"276","author":"MA Benson","year":"2001","unstructured":"Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232\u201324241","journal-title":"J Biol Chem"},{"key":"9288_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2004.06.002","volume":"79","author":"RA Bevins","year":"2004","unstructured":"Bevins RA, Peterson JL (2004) Individual differences in rats\u2019 reactivity to novelty and the unconditioned and conditioned locomotor effects of methamphetamine. Pharmacol Biochem Behav 79:65\u201374","journal-title":"Pharmacol Biochem Behav"},{"key":"9288_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/1734","volume":"20","author":"JL Blouin","year":"1998","unstructured":"Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G et al (1998) Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 20:70\u201373","journal-title":"Nat Genet"},{"key":"9288_CR19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","volume":"47","author":"DL Braff","year":"1990","unstructured":"Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47:181\u2013188","journal-title":"Arch Gen Psychiatry"},{"key":"9288_CR20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(00)00139-0","volume":"49","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Light GA, Sprock J, Perry W, Cadenhead KS et al (2001) Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia. Schizophr Res 49:171\u2013178","journal-title":"Schizophr Res"},{"key":"9288_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0074-7742(09)88005-7","volume":"88","author":"JL Cadet","year":"2009","unstructured":"Cadet JL, Krasnova IN (2009) Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol 88:101\u2013119","journal-title":"Int Rev Neurobiol"},{"key":"9288_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3565(24)35084-0","volume":"291","author":"J Cartmell","year":"1999","unstructured":"Cartmell J, Monn JA, Schoepp DD (1999) The metabotropic glutamate 2\/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291:161\u2013170","journal-title":"J Pharmacol Exp Ther"},{"key":"9288_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.62.2.137","volume":"52","author":"CLM Caton","year":"2005","unstructured":"Caton CLM, Drake RE, Hasin DS, Domingues B, Shrout PE, Samet S et al (2005) Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Arch Gen Psychiatry 52:137\u2013145","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"9288_CR24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1360-0443.2006.01782.x","volume":"102","author":"L Chang","year":"2007","unstructured":"Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1):16\u201332","journal-title":"Addiction"},{"key":"9288_CR25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S0033291703008353","volume":"33","author":"CK Chen","year":"2003","unstructured":"Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC et al (2003) Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 33:1407\u20131414","journal-title":"Psychol Med"},{"key":"9288_CR26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00041444-200412000-00011","volume":"14","author":"CK Chen","year":"2004","unstructured":"Chen CK, Hu X, Lin SK, Sham PC, Loh EW, Li T et al (2004) Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. Psychiatr Genet 14:223\u2013226","journal-title":"Psychiatr Genet"},{"key":"9288_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ajmg.b.30187","volume":"136","author":"CK Chen","year":"2005","unstructured":"Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Murray RM (2005) Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet 136:87\u201391","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1440-1819.2007.01696.x","volume":"61","author":"CK Chen","year":"2007","unstructured":"Chen CK, Lin SK, Huang MC, Su LW, Hsiao CC, Chiang YL et al (2007) Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusers. Psychiatry Clin Neurosci 61:479\u2013486","journal-title":"Psychiatry Clin Neurosci"},{"key":"9288_CR29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/417405a","volume":"417","author":"MY Cheng","year":"2002","unstructured":"Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J et al (2002) Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 417:405\u2013410","journal-title":"Nature"},{"key":"9288_CR30","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1080\/10826080701209341","volume":"42","author":"DR Christian","year":"2007","unstructured":"Christian DR, Huber A, Brecht M-L, McCann MJ, Marinelli-Casey P, Lord RH et al (2007) Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample. Subst Use Misuse 42:2207\u20132222","journal-title":"Subst Use Misuse"},{"key":"9288_CR31","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1073\/pnas.182412499","volume":"99","author":"I Chumakov","year":"2002","unstructured":"Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99:13675\u201313680","journal-title":"Proc Natl Acad Sci USA"},{"key":"9288_CR32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00213-004-1786-x","volume":"173","author":"KJ Clemens","year":"2004","unstructured":"Clemens KJ, van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS (2004) MDMA (\u201cecstasy\u201d), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology 173:318\u2013325","journal-title":"Psychopharmacology"},{"key":"9288_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2006.06.004","volume":"86","author":"KJ Clemens","year":"2007","unstructured":"Clemens KJ, Cornish JL, Hunt GE, McGregor IS (2007a) Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Drug Alcohol Depend 86:183\u2013190","journal-title":"Drug Alcohol Depend"},{"key":"9288_CR34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09595230601036945","volume":"26","author":"KJ Clemens","year":"2007","unstructured":"Clemens KJ, McGregor IS, Hunt GE, Cornish JL (2007b) MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev 26:9\u201315","journal-title":"Drug Alcohol Rev"},{"key":"9288_CR35","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00001756-199805110-00024","volume":"9","author":"D Cotter","year":"1998","unstructured":"Cotter D, Kerwin R, Al-Sarraji S, Brion JP, Chadwich A, Lovestone S et al (1998) Abnormalities of Wnt signalling in schizophrenia\u2013evidence for neurodevelopmental abnormality. Neuroreport 9:1379\u20131383","journal-title":"Neuroreport"},{"key":"9288_CR36","first-page":"161","volume-title":"Amphetamines and related stimulants: chemical, biological, clinical and social aspects","author":"JM Davis","year":"1980","unstructured":"Davis JM, Schlemmer FP Jr (1980) The amphetamine psychosis. In: Caldwell J (ed) Amphetamines and related stimulants: chemical, biological, clinical and social aspects. CRC Press, Boca Raton, pp 161\u2013173"},{"key":"9288_CR37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q","volume":"74","author":"SD Detera-Wadleigh","year":"1997","unstructured":"Detera-Wadleigh SD, Badner JA, Yoshikawa T, Sanders AR, Goldin LR, Turner G et al (1997) Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet 74:254\u2013262","journal-title":"Am J Med Genet"},{"key":"9288_CR38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.schres.2008.07.022","volume":"106","author":"TL Edwards","year":"2008","unstructured":"Edwards TL, Wang X, Chen Q, Wormly B, Riley B, O\u2019Neill FA et al (2008) Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia. Schizophr Res 106:208\u2013217","journal-title":"Schizophr Res"},{"key":"9288_CR39","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1196\/annals.1432.011","volume":"1139","author":"N Ezaki","year":"2008","unstructured":"Ezaki N, Nakamura K, Sekine Y, Thanseem I, Anitha A, Iwata Y et al (2008) Short allele of 5-HTTLPR as a risk factor for the development of psychosis in Japanese methamphetamine abusers. Ann N Y Acad Sci 1139:49\u201356","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biopsych.2007.11.023","volume":"64","author":"AH Fanous","year":"2008","unstructured":"Fanous AH, Neale MC, Webb BT, Straub RE, O\u2019Neill FA, Walsh D et al (2008) Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families. Biol Psychiatry 64:121\u2013127","journal-title":"Biol Psychiatry"},{"key":"9288_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291702006402","volume":"33","author":"DM Fergusson","year":"2003","unstructured":"Fergusson DM, Horwood LF, Swain-Campbell NR (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med 33:15\u201321","journal-title":"Psychol Med"},{"key":"9288_CR42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","volume":"47","author":"AE Fleckenstein","year":"2007","unstructured":"Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681\u2013698","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"9288_CR43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/appi.neuropsych.14.2.239-a","volume":"14","author":"D Fujii","year":"2002","unstructured":"Fujii D (2002) Risk factors for treatment-resistive methamphetamine psychosis. J Neuropsychiatry Clin Neurosci 14(2):239\u2013240","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9288_CR44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.pnpbp.2010.06.006","volume":"34","author":"T Futamura","year":"2010","unstructured":"Futamura T, Akiyama S, Sugino H, Forbes A, McQuade RD, Kikuchi T (2010) Aripiprazole attenuates established behavioral sensitization induced by methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 34:1115\u20131119","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR45","first-page":"787","volume-title":"Psychopharmacology: the fourth generation of progress","author":"MA Geyer","year":"1995","unstructured":"Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 787\u2013798"},{"key":"9288_CR46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jsat.2007.12.004","volume":"35","author":"S Glasner-Edwards","year":"2008","unstructured":"Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson R et al (2008) Clinical course and outcomes of methamphetamine-dependent adults with psychosis. J Subst Abuse Treat 35:445\u2013450","journal-title":"J Subst Abuse Treat"},{"key":"9288_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/10550490601184159","volume":"16","author":"KM Grant","year":"2007","unstructured":"Grant KM, Kelley SS, Agrawal S, Meza JL, Meyer JR, Romberger DJ (2007) Methamphetamine use in rural midwesterners. Am J Addict 16:79\u201384","journal-title":"Am J Addict"},{"key":"9288_CR48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/318788","volume":"68","author":"HM Gurling","year":"2001","unstructured":"Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS et al (2001) Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 68:661\u2013673","journal-title":"Am J Hum Genet"},{"key":"9288_CR49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2010.11.009","volume":"217","author":"M Hadamitzky","year":"2011","unstructured":"Hadamitzky M, Markou A, Kuczenski R (2011) Extended access to methamphetamine self-administration affects sensorimotor gating in rats. Behav Brain Res 217:386\u2013390","journal-title":"Behav Brain Res"},{"key":"9288_CR50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10550490050172209","volume":"9","author":"D Harris","year":"2000","unstructured":"Harris D, Batki SL (2000) Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 9:28\u201337","journal-title":"Am J Addict"},{"key":"9288_CR51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0269881108089818","volume":"22","author":"PJ Harrison","year":"2008","unstructured":"Harrison PJ, Lyon L, Sartorius LJ, Burnet PW, Lane TA (2008) The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia. J Psychopharmacol 22:308\u2013322","journal-title":"J Psychopharmacol"},{"key":"9288_CR52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30164","volume":"135B","author":"T Hashimoto","year":"2005","unstructured":"Hashimoto T, Hashimoto K, Matsuzawa D, Shimizu E, Sekine Y, Inada T et al (2005) A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. Am J Med Genet B Neuropsychiatr Genet 135B:5\u20139","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1461145704004663","volume":"7","author":"YY Huang","year":"2004","unstructured":"Huang YY, Battistuzzi C, Oquendo MA, Harkavy-Friedman J, Greenhill L, Zalsman G et al (2004) Human 5-HT1A receptor C(\u22121019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 7:441\u2013451","journal-title":"Int J Neuropsychopharmacol"},{"key":"9288_CR54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1196\/annals.1316.039","volume":"1025","author":"S Ide","year":"2004","unstructured":"Ide S, Kobayashi H, Tanaka K, Ujike H, Sekine Y, Ozaki N et al (2004) Gene polymorphisms of the mu opioid receptor in methamphetamine abusers. Ann N Y Acad Sci 1025:316\u2013324","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.tpj.6500355","volume":"6","author":"S Ide","year":"2006","unstructured":"Ide S, Kobayashi H, Ujike H, Ozaki N, Sekine Y, Inada T et al (2006) Linkage disequilibrium and association with methamphetamine dependence\/psychosis of mu-opioid receptor gene polymorphisms. Pharmacogenomics J 6:179\u2013188","journal-title":"Pharmacogenomics J"},{"key":"9288_CR56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1046\/j.1460-9568.2002.02140.x","volume":"16","author":"M Iijima","year":"2002","unstructured":"Iijima M, Nikaido T, Akiyama M, Moriya T, Shibata S (2002) Methamphetamine-induced, suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. Eur J Neurosci 16:921\u2013929","journal-title":"Eur J Neurosci"},{"key":"9288_CR57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145705005481","volume":"9","author":"M Ikeda","year":"2006","unstructured":"Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshiya Y et al (2006) Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. Int J Neuropsychopharmacol 9:77\u201381","journal-title":"Int J Neuropsychopharmacol"},{"key":"9288_CR58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1601-183X.2006.00237.x","volume":"6","author":"M Ikeda","year":"2007","unstructured":"Ikeda M, Ozaki N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y et al (2007) Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav 6:107\u2013112","journal-title":"Genes Brain Behav"},{"key":"9288_CR59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1196\/annals.1316.003","volume":"1025","author":"T Inada","year":"2004","unstructured":"Inada T, Iijima Y, Uchida N, Maeda T, Iwashita S, Ozaki N et al (2004) No association found between the type 1 sigma receptor gene polymorphisms and methamphetamine abuse in the Japanese population: a collaborative study by the Japanese Genetics Initiative for Drug Abuse. Ann N Y Acad Sci 1025:27\u201333","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajmg.b.30097","volume":"132B","author":"K Itoh","year":"2005","unstructured":"Itoh K, Hashimoto K, Shimizu E, Sekine Y, Ozaki N, Inada T et al (2005) Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am J Med Genet B Neuropsychiatr Genet 132B:70\u201373","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0447.1994.tb01541.x","volume":"89","author":"A Iwanami","year":"1994","unstructured":"Iwanami A, Sugiyama A, Kuroki N, Toda S, Kato N, Nakatani Y et al (1994) Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. Acta Psychiatr Scand 89:428\u2013432","journal-title":"Acta Psychiatr Scand"},{"key":"9288_CR62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1316.004","volume":"1025","author":"N Iwata","year":"2004","unstructured":"Iwata N, Inada T, Harano M, Komiyama T, Yamada M, Sekine Y et al (2004) No association is found between the candidate genes of t-PA\/plasminogen system and Japanese methamphetamine-related disorder: a collaborative study by the Japanese Genetics Initiative for Drug Abuse. Ann N Y Acad Sci 1025:34\u201338","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR63","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1196\/annals.1316.036","volume":"1025","author":"M Iyo","year":"2004","unstructured":"Iyo M, Sekine Y, Mori N (2004) Neuromechanism of developing methamphetamine psychosis: a neuroimaging study. Ann N Y Acad Sci 1025:288\u2013295","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/npp.2009.155","volume":"35","author":"A Izquierdo","year":"2010","unstructured":"Izquierdo A, Belcher AM, Scott L, Cazares VA, Chen J, O\u2019Dell SJ et al (2010) Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharmacology 35:505\u2013514","journal-title":"Neuropsychopharmacology"},{"key":"9288_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2005.07.026","volume":"143","author":"SH Jeong","year":"2006","unstructured":"Jeong SH, Joo EJ, Ahn YM, Lee KY, Kim YS (2006) Investigation of genetic association between human Frizzled homolog 3 gene (FZD3) and schizophrenia: results in a Korean population and evidence from meta-analysis. Psychiatry Res 143:1\u201311","journal-title":"Psychiatry Res"},{"key":"9288_CR66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.mp.4000841","volume":"6","author":"A Joo","year":"2001","unstructured":"Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y (2001) Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia. Mol Psychiatry 6:186\u2013192","journal-title":"Mol Psychiatry"},{"key":"9288_CR67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ajmg.b.30797","volume":"150B","author":"N Kanahara","year":"2009","unstructured":"Kanahara N, Miyatake R, Sekine Y, Inada T, Ozaki N, Iwata N et al (2009) Association study between the PIK4CA gene and methamphetamine use disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 150B:233\u2013238","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2010.05.012","volume":"121","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF et al (2010) High dose D-serine in the treatment of schizophrenia. Schizophr Res 121:125\u2013130","journal-title":"Schizophr Res"},{"key":"9288_CR69","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0006-3223(89)90270-9","volume":"25","author":"Y Kazahaya","year":"1989","unstructured":"Kazahaya Y, Akimoto K, Otsuki S (1989) Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo. Biol Psychiatry 25:903\u2013912","journal-title":"Biol Psychiatry"},{"key":"9288_CR70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0028-3908(02)00084-9","volume":"43","author":"JN Kew","year":"2002","unstructured":"Kew JN, Pflimlin MC, Kemp JA, Mutel V (2002) Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 \u2212\/\u2212 mice. Neuropharmacology 43:215\u2013221","journal-title":"Neuropharmacology"},{"key":"9288_CR71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1196\/annals.1432.021","volume":"1139","author":"Y Kinoshita","year":"2008","unstructured":"Kinoshita Y, Ikeda M, Ujike H, Kitajima T, Yamanouchi Y, Aleksic B et al (2008) Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population. Ann N Y Acad Sci 1139:57\u201362","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1196\/annals.1432.024","volume":"1139","author":"T Kishi","year":"2008","unstructured":"Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K et al (2008) Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population. Ann N Y Acad Sci 1139:83\u201388","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR73","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.pnpbp.2009.04.008","volume":"33","author":"T Kishi","year":"2009","unstructured":"Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K et al (2009a) A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis. Prog Neuropsychopharmacol Biol Psychiatry 33:895\u2013898","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR74","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/jhg.2009.84","volume":"54","author":"T Kishi","year":"2009","unstructured":"Kishi T, Tsunoka T, Ikeda M, Kawashima K, Okochi T, Kitajima T et al (2009b) Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J Hum Genet 54:629\u2013633","journal-title":"J Hum Genet"},{"key":"9288_CR75","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuropharm.2009.09.006","volume":"58","author":"T Kishi","year":"2009","unstructured":"Kishi T, Tsunoka T, Ikeda M, Kitajima T, Kawashima K, Okochi T et al (2009c) Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients. Neuropharmacology 58:452\u2013456","journal-title":"Neuropharmacology"},{"key":"9288_CR76","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.pnpbp.2010.05.018","volume":"34","author":"T Kishi","year":"2010","unstructured":"Kishi T, Kitajima T, Tsunoka T, Okumura T, Okochi T, Kawashima K et al (2010) PR0KR2 is associated with methamphetamine dependence in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 34:1033\u20131036","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopsych.2007.03.019","volume":"63","author":"M Kishimoto","year":"2008","unstructured":"Kishimoto M, Ujike H, Motohashi Y, Tanaka Y, Okahisa Y, Kotaka T et al (2008a) The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 63:191\u2013196","journal-title":"Biol Psychiatry"},{"key":"9288_CR78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1744-9081-4-37","volume":"4","author":"M Kishimoto","year":"2008","unstructured":"Kishimoto M, Ujike H, Okahisa Y, Kotaka T, Takaki M, Kodama M et al (2008b) The Frizzled 3 gene is associated with methamphetamine psychosis in the Japanese population. Behav Brain Funct 4:37","journal-title":"Behav Brain Funct"},{"key":"9288_CR79","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajmg.b.30337","volume":"141B","author":"H Kobayashi","year":"2006","unstructured":"Kobayashi H, Hata H, Ujike H, Harano M, Inada T, Komiyama T et al (2006) Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence\/psychosis. Am J Med Genet B Neuropsychiatr Genet 141B:482\u2013486","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR80","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1196\/annals.1316.040","volume":"1025","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi H, Ide S, Hasegawa J, Ujike H, Sekine Y, Ozaki N et al (2004) Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis\/dependence. Ann N Y Acad Sci 1025:325\u2013334","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ajmg.b.20148","volume":"126B","author":"H Koizumi","year":"2004","unstructured":"Koizumi H, Hashimoto K, Kumakiri C, Shimizu E, Sekine Y, Ozaki N et al (2004) Association between the glutathione S-transferase M1 gene deletion and female methamphetamine abusers. Am J Med Genet B Neuropsychiatr Genet 126B:43\u201345","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00328-5","volume":"97","author":"C Konradi","year":"2003","unstructured":"Konradi C, Heckers S (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 97:153\u2013179","journal-title":"Pharmacol Ther"},{"key":"9288_CR83","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1471-4159.2010.06834.x","volume":"114","author":"LM Kosloski","year":"2010","unstructured":"Kosloski LM, Ha DM, Hutter JA, Stone DK, Pichler MR, Reynolds AD et al (2010) Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases. J Neurochem 114:1261\u20131276","journal-title":"J Neurochem"},{"key":"9288_CR84","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1196\/annals.1432.025","volume":"1139","author":"T Kotaka","year":"2008","unstructured":"Kotaka T, Ujike H, Morita Y, Kishimoto M, Okahisa Y, Inada T et al (2008) Association study between casein kinase 1 epsilon gene and methamphetamine dependence. Ann N Y Acad Sci 1139:43\u201348","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR85","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.pnpbp.2009.05.017","volume":"33","author":"T Kotaka","year":"2009","unstructured":"Kotaka T, Ujike H, Okahisa Y, Takaki M, Nakata K, Kodama M et al (2009) G72 gene is associated with susceptibility to methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry 33:1046\u20131049","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR86","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2009.03.002","volume":"60","author":"IN Krasnova","year":"2009","unstructured":"Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379\u2013407","journal-title":"Brain Res Rev"},{"key":"9288_CR87","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/npp.2009.73","volume":"34","author":"R Kuczenski","year":"2009","unstructured":"Kuczenski R, Segal DS, Melega WP, Lacan G, McCunney SJ (2009) Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge. Neuropsychopharmacology 34:2430\u20132441","journal-title":"Neuropsychopharmacology"},{"key":"9288_CR88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1196\/annals.1432.026","volume":"1139","author":"DM Kuhn","year":"2008","unstructured":"Kuhn DM, Francescutti-Verbeem DM, Thomas DM (2008) Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity. Ann N Y Acad Sci 1139:118\u2013126","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR89","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1748-0361.2008.00162.x","volume":"24","author":"D Lambert","year":"2008","unstructured":"Lambert D, Gale JA, Hartley D (2008) Substance abuse by youth and young adults in rural America. J Rural Health 24:221\u2013228","journal-title":"J Rural Health"},{"key":"9288_CR90","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuropharm.2008.06.046","volume":"55","author":"B Francois Le","year":"2008","unstructured":"Le Francois B, Czesak M, Steubl D, Albert PR (2008) Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55:977\u2013985","journal-title":"Neuropharmacology"},{"key":"9288_CR91","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1521-0391.2009.00014.x","volume":"19","author":"MH Leamon","year":"2010","unstructured":"Leamon MH, Flower K, Salo RE, Nordahl TE, Kranzler HR, Galloway GP (2010) Methamphetamine and paranoia: the methamphetamine experience questionnaire. Am J Addict 19:155\u2013168","journal-title":"Am J Addict"},{"issue":"suppl 3","key":"9288_CR92","first-page":"S43","volume":"88","author":"T Leelahanaj","year":"2005","unstructured":"Leelahanaj T, Kongsakon R, Netrakom P (2005) A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis. J Med Assoc Thai 88(suppl 3):S43\u2013S52","journal-title":"J Med Assoc Thai"},{"key":"9288_CR93","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1523\/JNEUROSCI.23-25-08788.2003","volume":"23","author":"S Lemonde","year":"2003","unstructured":"Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD et al (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788\u20138799","journal-title":"J Neurosci"},{"key":"9288_CR94","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1461145704004699","volume":"7","author":"S Lemonde","year":"2004","unstructured":"Lemonde S, Du L, Bakish D, Hrdina P, Albert PR (2004) Association of the C(\u22121019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 7:501\u2013506","journal-title":"Int J Neuropsychopharmacol"},{"key":"9288_CR95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ajmg.b.30024","volume":"129B","author":"T Li","year":"2004","unstructured":"Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W et al (2004) Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet 129B:120\u2013124","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ng1229","volume":"35","author":"W Li","year":"2003","unstructured":"Li W, Zhang Q, Oiso N, Novak EK, Gautam R, O\u2019brien EP et al (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat Genet 35:84\u201389","journal-title":"Nat Genet"},{"key":"9288_CR97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00041444-200403000-00005","volume":"14","author":"HC Liu","year":"2004","unstructured":"Liu HC, Lin SK, Liu SK, Chen SL, Hu CJ, Chang JG et al (2004) DAT polymorphism and diverse clinical manifestations in methamphetamine abusers. Psychiatr Genet 14:33\u201337","journal-title":"Psychiatr Genet"},{"key":"9288_CR98","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1819.2006.01490.x","volume":"60","author":"HC Liu","year":"2006","unstructured":"Liu HC, Chen CK, Leu SJ, Wu HT, Lin SK (2006) Association between dopamine receptor D1 A-48\u00a0G polymorphism and methamphetamine abuse. Psychiatry Clin Neurosci 60:226\u2013231","journal-title":"Psychiatry Clin Neurosci"},{"key":"9288_CR99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/dbio.1997.8734","volume":"192","author":"FR Lucas","year":"1997","unstructured":"Lucas FR, Salinas PC (1997) WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. Dev Biol 192:31\u201344","journal-title":"Dev Biol"},{"key":"9288_CR100","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/syn.20553","volume":"62","author":"L Lyon","year":"2008","unstructured":"Lyon L, Kew JN, Corti C, Harrison PJ, Burnet PW (2008) Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice. Synapse 62:842\u2013850","journal-title":"Synapse"},{"key":"9288_CR101","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/schbul\/18.1.107","volume":"18","author":"Y Machiyama","year":"1992","unstructured":"Machiyama Y (1992) Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophr Bull 18:107\u2013113","journal-title":"Schizophr Bull"},{"key":"9288_CR102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pbb.2008.06.023","volume":"91","author":"S Maehara","year":"2008","unstructured":"Maehara S, Hikichi H, Satow A, Okuda S, Ohta H (2008) Antipsychotic property of a muscarinic receptor agonist in animal models of schizophrenia. Pharmacol Biochem Behav 91:140\u2013149","journal-title":"Pharmacol Biochem Behav"},{"key":"9288_CR103","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10550490701861201","volume":"17","author":"JJ Mahoney 3rd","year":"2008","unstructured":"Mahoney JJ 3rd, Kalechstein AD, De La Garza R 2nd, Newton TF (2008) Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependence participants. Am J Addict 17:83\u201398","journal-title":"Am J Addict"},{"key":"9288_CR104","first-page":"115","volume":"61","author":"TC Manschreck","year":"1988","unstructured":"Manschreck TC, Laughery JA, Weisstein CC, Allen D, Humblestone B, Neville M et al (1988) Characteristics of freebase cocaine psychosis. Yale J Biol Med 61:115\u2013122","journal-title":"Yale J Biol Med"},{"key":"9288_CR105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/npp.2008.173","volume":"34","author":"A Markou","year":"2009","unstructured":"Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T (2009) Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 34:74\u201389","journal-title":"Neuropsychopharmacology"},{"key":"9288_CR106","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.biopsych.2005.02.005","volume":"57","author":"V Martinez","year":"2005","unstructured":"Martinez V, Parikh V, Sarter M (2005) Sensitized attentional performance and Fos-immunoreactive cholinergic neurons in the basal forebrain of amphetamine-pretreated rats. Biol Psychiatry 57:1138\u20131146","journal-title":"Biol Psychiatry"},{"key":"9288_CR107","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1360-0443.2002.00143.x","volume":"97","author":"T Matsumoto","year":"2002","unstructured":"Matsumoto T, Karmijo A, Miyakawa T, Endo K, Yabana T, Kishimoto H et al (2002) Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 97:809\u2013817","journal-title":"Addiction"},{"key":"9288_CR108","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/appi.ajp.164.7.1105","volume":"164","author":"D Matsuzawa","year":"2007","unstructured":"Matsuzawa D, Hashimoto K, Miyatake R, Shirayama Y, Shimizu E, Maeda K et al (2007) Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Am J Psychiatry 164:1105\u20131114","journal-title":"Am J Psychiatry"},{"key":"9288_CR109","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/138161210790361470","volume":"16","author":"AC Mccreary","year":"2010","unstructured":"Mccreary AC, Jones CA (2010) Antipsychotic medication: the potential role of 5-HT(1A) receptor agonism. Curr Pharm Des 16:516\u2013521","journal-title":"Curr Pharm Des"},{"key":"9288_CR110","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1360-0443.2006.01496.x","volume":"101","author":"R McKetin","year":"2006","unstructured":"McKetin R, McLaren J, Lubman DI, Hides L (2006) The prevalence of psychotic symptoms among methamphetamine users. Addiction 101:1473\u20131478","journal-title":"Addiction"},{"key":"9288_CR111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09595230801919486","volume":"27","author":"R McKetin","year":"2008","unstructured":"McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI et al (2008) Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 27:277\u2013285","journal-title":"Drug Alcohol Rev"},{"key":"9288_CR112","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00004714-200006000-00023","volume":"20","author":"LK Misra","year":"2000","unstructured":"Misra LK, Kofoed L, Oesterheld JR, Richards GA (2000) Olanzapine treatment of methamphetamine psychosis. J Clin Psychopharmacol 20:393\u2013394","journal-title":"J Clin Psychopharmacol"},{"key":"9288_CR113","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-009-1651-z","volume":"207","author":"H Mizoguchi","year":"2009","unstructured":"Mizoguchi H, Arai S, Koike H, Ibi D, Kamei H, Nabeshima T et al (2009) Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons. Psychopharmacology 207:235\u2013243","journal-title":"Psychopharmacology"},{"key":"9288_CR114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.15288\/jsa.1994.55.173","volume":"55","author":"RH Moos","year":"1994","unstructured":"Moos RH, Brennan PL, Mertens JR (1994) Diagnostic subgroups and predictors of one-year re-admission among late-middle-aged and older substance abuse patients. J Stud Alcohol 55:173\u2013183","journal-title":"J Stud Alcohol"},{"key":"9288_CR115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1196\/annals.1369.041","volume":"1074","author":"A Morio","year":"2006","unstructured":"Morio A, Ujike H, Nomura A, Tanaka Y, Morita Y, Otani K et al (2006) No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence. Ann N Y Acad Sci 1074:411\u2013417","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR116","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2004.11.050","volume":"376","author":"Y Morita","year":"2005","unstructured":"Morita Y, Ujike H, Tanaka Y, Uchida N, Nomura A, Ohtani K et al (2005a) A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia. Neurosci Lett 376:182\u2013187","journal-title":"Neurosci Lett"},{"key":"9288_CR117","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neulet.2005.04.014","volume":"383","author":"Y Morita","year":"2005","unstructured":"Morita Y, Ujike H, Tanaka Y, Uchida N, Nomura A, Otani K et al (2005b) The X-box binding protein 1 (XBP1) gene is not associated with methamphetamine dependence. Neurosci Lett 383:194\u2013198","journal-title":"Neurosci Lett"},{"key":"9288_CR118","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ajmg.b.30565","volume":"147B","author":"Y Morita","year":"2008","unstructured":"Morita Y, Ujike H, Tanaka Y, Kishimoto M, Okahisa Y, Kotaka T et al (2008) The glycine transporter 1 gene (GLYT1) is associated with methamphetamine-use disorder. Am J Med Genet B Neuropsychiatr Genet 147B:54\u201358","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2009.12.018","volume":"222","author":"RL Mosley","year":"2010","unstructured":"Mosley RL, Gendelman HE (2010) Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders. Exp Neurol 222:1\u20135","journal-title":"Exp Neurol"},{"key":"9288_CR120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/10550490802268462","volume":"17","author":"H Nakama","year":"2008","unstructured":"Nakama H, Chang L, Cloak C, Jiang C, Alicata D, Haning W (2008) Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict 17:441\u2013446","journal-title":"Am J Addict"},{"key":"9288_CR121","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2009.02.048","volume":"455","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Chen CK, Sekine Y, Iwata Y, Anitha A, Loh El W et al (2009) An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. Neurosci Lett 455:120\u2013123","journal-title":"Neurosci Lett"},{"key":"9288_CR122","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","volume":"10","author":"EJ Nestler","year":"2001","unstructured":"Nestler EJ (2001) Molecular neurobiology of addiction. Am J Addict 10:201\u2013217","journal-title":"Am J Addict"},{"key":"9288_CR123","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1126\/science.1112103","volume":"308","author":"KL Ng","year":"2005","unstructured":"Ng KL, Li JD, Cheng MY, Leslie FM, Lee AG, Zhou QY (2005) Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 308:1923\u20131927","journal-title":"Science"},{"key":"9288_CR124","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(83)90006-7","volume":"88","author":"T Nishikawa","year":"1983","unstructured":"Nishikawa T, Mataga N, Takashima M, Toru M (1983) Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur J Pharmacol 88:195\u2013203","journal-title":"Eur J Pharmacol"},{"key":"9288_CR125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.tpj.6500292","volume":"5","author":"T Nishiyama","year":"2005","unstructured":"Nishiyama T, Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y et al (2005) Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics J 5:89\u201395","journal-title":"Pharmacogenomics J"},{"key":"9288_CR126","unstructured":"NSDUH Substance Abuse and Mental Health Services Administration (2009) Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09\u20134434) Rockville, MD, pp 242\u2013243"},{"key":"9288_CR127","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13556210500123423","volume":"10","author":"S Ohgake","year":"2005","unstructured":"Ohgake S, Hashimoto K, Shimizu E, Koizumi H, Okamura N, Koike K et al (2005) Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis. Addict Biol 10:145\u2013148","journal-title":"Addict Biol"},{"key":"9288_CR128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1440-1819.2009.01961.x","volume":"63","author":"Y Okahisa","year":"2009","unstructured":"Okahisa Y, Ujike H, Kotaka T, Morita Y, Kodama M, Inada T et al (2009) Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. Psychiatry Clin Neurosci 63:417\u2013422","journal-title":"Psychiatry Clin Neurosci"},{"key":"9288_CR129","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.pnpbp.2009.04.016","volume":"33","author":"T Okochi","year":"2009","unstructured":"Okochi T, Kishi T, Ikeda M, Kitajima T, Kinoshita Y, Kawashima K et al (2009) Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 33:903\u2013905","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.bjp.0701164","volume":"121","author":"S Okuyama","year":"1997","unstructured":"Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T et al (1997) The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats. Br J Pharmacol 121:515\u2013525","journal-title":"Br J Pharmacol"},{"key":"9288_CR131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajmg.1320600316","volume":"60","author":"AE Pulver","year":"1995","unstructured":"Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL et al (1995) Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 60:252\u2013260","journal-title":"Am J Med Genet"},{"key":"9288_CR132","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0740-5472(02)00256-8","volume":"23","author":"RA Rawson","year":"2002","unstructured":"Rawson RA, Gonzales R, Brethen P (2002) Treatment of methamphetamine use disorder: an update. J Subst Abuse Treat 23:145\u2013150","journal-title":"J Subst Abuse Treat"},{"key":"9288_CR133","doi-asserted-by":"crossref","unstructured":"Reichel CM, Schwendt M, McGinty J, Olive MF, See RE (2011) Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology [advance online publication]","DOI":"10.1038\/npp.2010.212"},{"key":"9288_CR134","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","volume":"396","author":"TE Robinson","year":"1986","unstructured":"Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157\u2013198","journal-title":"Brain Res"},{"key":"9288_CR135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/YPG.0b013e3283050aa5","volume":"18","author":"J Ross","year":"2008","unstructured":"Ross J, Berrettini W, Coryell W, Gershon ES, Badner JA, Kelsoe JR et al (2008) Genome-wide parametric linkage analyses of 644 bipolar pedigrees suggest susceptibility loci at chromosomes 16 and 20. Psychiatr Genet 18:191\u2013198","journal-title":"Psychiatr Genet"},{"key":"9288_CR136","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23\u201340","journal-title":"Eur J Pharmacol"},{"key":"9288_CR137","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1991.01810250045005","volume":"48","author":"BJ Rounsaville","year":"1991","unstructured":"Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43\u201351","journal-title":"Arch Gen Psychiatry"},{"key":"9288_CR138","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.psychres.2007.04.018","volume":"157","author":"R Salo","year":"2008","unstructured":"Salo R, Nordahl TE, Leamon MH, Natsuaki Y, Moore CD, Waters C et al (2008) Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res 157:273\u2013277","journal-title":"Psychiatry Res"},{"key":"9288_CR139","unstructured":"SAMHSA [Substance Abuse and Mental Health Services Administration], Office of Applied Studies (2009) Treatment Episode Data Set (TEDS) 1998\u20132008, National Admissions to Substance Abuse Treatment Services, Drugs and Alcohol Services Information System Series: S-50, HHS Publication No. (SMA) 09\u20134471, Rockville, MD, 52"},{"key":"9288_CR140","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1038\/sj.npp.1301669","volume":"33","author":"LJ Sartorius","year":"2008","unstructured":"Sartorius LJ, Weinberger DR, Hyde TM, Harrison PJ, Kleinman JE, Lipska BK (2008) Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP. Neuropsychopharmacology 33:2626\u20132634","journal-title":"Neuropsychopharmacology"},{"key":"9288_CR141","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.1992.tb25965.x","volume":"654","author":"M Sato","year":"1992","unstructured":"Sato M (1992) A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 654:160\u2013170","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR142","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.mp.4001421","volume":"9","author":"J Schumacher","year":"2004","unstructured":"Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte AC et al (2004) Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 9:203\u2013207","journal-title":"Mol Psychiatry"},{"key":"9288_CR143","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(74)90060-4","volume":"2","author":"DS Segal","year":"1974","unstructured":"Segal DS, Mandell AJ (1974) Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem Behav 2:249\u2013255","journal-title":"Pharmacol Biochem Behav"},{"key":"9288_CR144","first-page":"95","volume":"5","author":"DS Segal","year":"1981","unstructured":"Segal DS, Geyer MA, Schuckit MA (1981) Stimulant-induced psychosis: an evaluation of animal methods. Essays Neurochem Neuropharmacol 5:95\u2013129","journal-title":"Essays Neurochem Neuropharmacol"},{"key":"9288_CR145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(24)36838-7","volume":"282","author":"DS Segal","year":"1997","unstructured":"Segal DS, Kuczenski R (1997) Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J Pharmacol Exp Ther 282:561\u2013573","journal-title":"J Pharmacol Exp Ther"},{"key":"9288_CR146","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-3565(24)35066-9","volume":"291","author":"DS Segal","year":"1999","unstructured":"Segal DS, Kuczenski R (1999) Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile. J Pharmacol Exp Ther 291:19\u201330","journal-title":"J Pharmacol Exp Ther"},{"key":"9288_CR147","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.158.8.1206","volume":"158","author":"Y Sekine","year":"2001","unstructured":"Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H et al (2001) Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 158:1206\u20131214","journal-title":"Am J Psychiatry"},{"key":"9288_CR148","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1176\/appi.ajp.160.9.1699","volume":"160","author":"Y Sekine","year":"2003","unstructured":"Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K et al (2003) Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160:1699\u20131701","journal-title":"Am J Psychiatry"},{"key":"9288_CR149","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0278-5846(96)00082-6","volume":"20","author":"T Shinba","year":"1996","unstructured":"Shinba T, Yamamoto K, Cao GM, Mugishima G, Andow Y, Hoshino T (1996) Effects of acute methamphetamine administration on spacing in paired rats: investigation with an automated video-analysis method. Prog Neuropsychopharmacol Biol Psychiatry 20:1037\u20131049","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Suppl1","key":"9288_CR150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/02791072.2003.10400511","volume":"35","author":"S Shoptaw","year":"2003","unstructured":"Shoptaw S, Peck J, Reback FJ, Rotheram-Fuller E (2003) Psychiatric and susbstance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependenct gay and bisexual men seeking outpatient drug abuse treatment. J Psychoactive Drugs 35(Suppl1):161\u2013168","journal-title":"J Psychoactive Drugs"},{"key":"9288_CR151","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145703003675","volume":"6","author":"M Srisurapanont","year":"2003","unstructured":"Srisurapanont M, Ali R, Marsden J, Sunga A, Wada K, Monteiro M (2003) Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol 6:347\u2013352","journal-title":"Int J Neuropsychopharmacol"},{"key":"9288_CR152","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1089\/ars.2009.2460","volume":"11","author":"DK Stone","year":"2009","unstructured":"Stone DK, Reynolds AD, Mosley RL, Gendelman HE (2009) Innate and adaptive immunity for the pathobiology of Parkinson\u2019s disease. Antioxid Redox Signal 11:2151\u20132166","journal-title":"Antioxid Redox Signal"},{"key":"9288_CR153","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/341750","volume":"71","author":"RE Straub","year":"2002","unstructured":"Straub RE, Jiang Y, Maclean CJ, Ma Y, Webb BT, Myakishev MV et al (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71:337\u2013348","journal-title":"Am J Hum Genet"},{"key":"9288_CR154","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.ypg.0000218613.35139.cd","volume":"16","author":"A Suzuki","year":"2006","unstructured":"Suzuki A, Nakamura K, Sekine Y, Minabe Y, Takei N, Suzuki K et al (2006) An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder. Psychiatr Genet 16:133\u2013138","journal-title":"Psychiatr Genet"},{"key":"9288_CR155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1139\/y93-050","volume":"71","author":"M Takigawa","year":"1993","unstructured":"Takigawa M, Maeda H, Ueyama K, Tominaga H, Matsumoto K (1993) A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia. Can J Physiol Pharmacol 71:321\u2013325","journal-title":"Can J Physiol Pharmacol"},{"key":"9288_CR156","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1172\/JCI200420425","volume":"113","author":"K Talbot","year":"2004","unstructured":"Talbot K, Eidem WL, Tinsley CL, Benson MA, Thompson EW, Smith RJ et al (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 113:1353\u20131363","journal-title":"J Clin Invest"},{"key":"9288_CR157","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1471-4159.2003.02182.x","volume":"88","author":"DM Thomas","year":"2004","unstructured":"Thomas DM, Francescutti-Verbeem DM, Liu X, Kuhn DM (2004a) Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment\u2013an oligonucleotide microarray approach. J Neurochem 88:380\u2013393","journal-title":"J Neurochem"},{"key":"9288_CR158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.104.070961","volume":"311","author":"DM Thomas","year":"2004","unstructured":"Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM (2004b) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 311:1\u20137","journal-title":"J Pharmacol Exp Ther"},{"key":"9288_CR159","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1471-4159.2007.05155.x","volume":"105","author":"DM Thomas","year":"2008","unstructured":"Thomas DM, Francescutti-Verbeem DM, Kuhn DM (2008a) The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 105:605\u2013616","journal-title":"J Neurochem"},{"key":"9288_CR160","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1471-4159.2008.05421.x","volume":"106","author":"DM Thomas","year":"2008","unstructured":"Thomas DM, Francescutti-Verbeem DM, Kuhn DM (2008b) Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling. J Neurochem 106:696\u2013705","journal-title":"J Neurochem"},{"key":"9288_CR161","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.pnpbp.2010.03.002","volume":"34","author":"T Tsunoka","year":"2010","unstructured":"Tsunoka T, Kishi T, Kitajima T, Okochi T, Okumura T, Yamanouchi Y et al (2010) Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 34:639\u2013644","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR162","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11920-002-0024-7","volume":"4","author":"H Ujike","year":"2002","unstructured":"Ujike H (2002) Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 4:177\u2013184","journal-title":"Curr Psychiatry Rep"},{"key":"9288_CR163","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1196\/annals.1316.035","volume":"1025","author":"H Ujike","year":"2004","unstructured":"Ujike H, Sato M (2004) Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann NY Acad Sci 1025:279\u2013287","journal-title":"Ann NY Acad Sci"},{"key":"9288_CR164","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0006-8993(88)90151-5","volume":"453","author":"H Ujike","year":"1988","unstructured":"Ujike H, Ogawa N, Otsuki S (1988) Effects of acute and long-term treatment with methamphetamine on substance P concentration and receptor numbers in the rat brain. Brain Res 453:136\u2013142","journal-title":"Brain Res"},{"key":"9288_CR165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00442011","volume":"98","author":"H Ujike","year":"1989","unstructured":"Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S (1989) Effect of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 98:89\u201392","journal-title":"Psychopharmacology"},{"key":"9288_CR166","doi-asserted-by":"crossref","first-page":"PL129","DOI":"10.1016\/0024-3205(92)90466-3","volume":"50","author":"H Ujike","year":"1992","unstructured":"Ujike H, Kanzaki A, Okumura K, Akiyama K, Otsuki S (1992) Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci 50:PL129\u2013PL134","journal-title":"Life Sci"},{"key":"9288_CR167","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/sj.tpj.6500189","volume":"3","author":"H Ujike","year":"2003","unstructured":"Ujike H, Harano M, Inada T, Yamada M, Komiyama T, Sekine Y et al (2003) Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J 3:242\u2013247","journal-title":"Pharmacogenomics J"},{"key":"9288_CR168","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1196\/annals.1369.008","volume":"1074","author":"H Ujike","year":"2006","unstructured":"Ujike H, Sakai A, Nakata K, Tanaka Y, Kodaka T, Okahisa Y et al (2006) Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis. Ann N Y Acad Sci 1074:90\u201396","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR169","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pnpbp.2009.02.019","volume":"33","author":"H Ujike","year":"2009","unstructured":"Ujike H, Katsu T, Okahisa Y, Takaki M, Kodama M, Inada T et al (2009) Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Prog Neuropsychopharmacol Biol Psychiatry 33:625\u2013629","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9288_CR170","unstructured":"UNODC United Nations Office on Drugs and Crime, World Drug Report (2009) http:\/\/www.unodc.org\/documents\/scientific\/ATS\/Global-ATS-Assessment-2009-Web.pdf , 280"},{"key":"9288_CR171","first-page":"687","volume":"13","author":"H Utena","year":"1961","unstructured":"Utena H (1961) A special type of model psychosis: a chronic methamphetamine intoxication in man and animal. Brain Nerve 13:687\u2013692","journal-title":"Brain Nerve"},{"key":"9288_CR172","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0079-6123(08)64231-4","volume":"21B","author":"H Utena","year":"1966","unstructured":"Utena H (1966) Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. Prog Brain Res 21B:192\u2013207","journal-title":"Prog Brain Res"},{"key":"9288_CR173","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","volume":"156","author":"J Os van","year":"2002","unstructured":"van Os J, Bak M, Hanssen M, Bijl RV, De Graaf R, Verdoux H (2002) Cannabis use and psychosis: a longitudinal population based study. Am J Epidemiol 156:319\u2013327","journal-title":"Am J Epidemiol"},{"key":"9288_CR174","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al (2001a) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015\u20132021","journal-title":"Am J Psychiatry"},{"key":"9288_CR175","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.21-23-09414.2001","volume":"21","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M et al (2001b) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21:9414\u20139418","journal-title":"J Neurosci"},{"key":"9288_CR176","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1176\/appi.ajp.158.3.377","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al (2001c) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377\u2013382","journal-title":"Am J Psychiatry"},{"issue":"Suppl 1","key":"9288_CR177","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1360-0443.2007.01771.x","volume":"102","author":"TJ Volz","year":"2007","unstructured":"Volz TJ, Fleckenstein AE, Hanson GR (2007) Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 102(Suppl 1):44\u201348","journal-title":"Addiction"},{"key":"9288_CR178","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1465-3362.2008.00016.x","volume":"28","author":"C Wallace","year":"2009","unstructured":"Wallace C, Galloway T, McKetin R, Kelly E, Leary J (2009) Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug Alcohol Rev 28:592\u2013599","journal-title":"Drug Alcohol Rev"},{"key":"9288_CR179","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cellsig.2005.12.008","volume":"18","author":"HY Wang","year":"2006","unstructured":"Wang HY, Liu T, Malbon CC (2006a) Structure-function analysis of Frizzleds. Cell Signal 18:934\u2013941","journal-title":"Cell Signal"},{"key":"9288_CR180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1523\/JNEUROSCI.3221-05.2006","volume":"26","author":"Y Wang","year":"2006","unstructured":"Wang Y, Zhang J, Mori S, Nathans J (2006b) Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling. J Neurosci 26:355\u2013364","journal-title":"J Neurosci"},{"key":"9288_CR181","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/hmg\/ddn130","volume":"17","author":"CS Weickert","year":"2008","unstructured":"Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, Radhakrishna V et al (2008) Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17:2293\u20132309","journal-title":"Hum Mol Genet"},{"key":"9288_CR182","first-page":"791","volume":"35","author":"C Weisner","year":"2000","unstructured":"Weisner C, Mertens J, Parthasarathy S, Moore C, Hunkeler EM, Hu T et al (2000) The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res 35:791\u2013812","journal-title":"Health Serv Res"},{"key":"9288_CR183","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","volume":"2","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2:699\u2013703","journal-title":"Nat Med"},{"key":"9288_CR184","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/syn.20185","volume":"58","author":"W Xu","year":"2005","unstructured":"Xu W, Zhu JP, Angulo JA (2005) Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 58:110\u2013121","journal-title":"Synapse"},{"key":"9288_CR185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2502\/janip1944.13.37","volume":"13","author":"M Yagi","year":"1963","unstructured":"Yagi M (1963) Factors influencing the general activity in rats: 2. Effects of methamphetamine. Ann Anim Psychol 13:37\u201347","journal-title":"Ann Anim Psychol"},{"key":"9288_CR186","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0006-3223(03)00291-9","volume":"54","author":"J Yang","year":"2003","unstructured":"Yang J, Si T, Ling Y, Ruan Y, Han Y, Wang X et al (2003) Association study of the human FZD3 locus with schizophrenia. Biol Psychiatry 54:1298\u20131301","journal-title":"Biol Psychiatry"},{"key":"9288_CR187","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.comppsych.2005.07.006","volume":"47","author":"CF Yen","year":"2006","unstructured":"Yen CF, Chong MY (2006) Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry 47:215\u2013220","journal-title":"Compr Psychiatry"},{"key":"9288_CR188","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2006.04137.x","volume":"99","author":"JH Yoo","year":"2006","unstructured":"Yoo JH, Cho JH, Yu HS, Lee KW, Lee BH, Jeong SM et al (2006) Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study. J Neurochem 99:976\u2013988","journal-title":"J Neurochem"},{"key":"9288_CR189","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00439-006-0189-y","volume":"120","author":"T Yoshikawa","year":"2006","unstructured":"Yoshikawa T, Lin SK, Mori N (2006) Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations. Hum Genet 120:243\u2013252","journal-title":"Hum Genet"},{"key":"9288_CR190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2007.01.056","volume":"416","author":"W Yue","year":"2007","unstructured":"Yue W, Kang G, Zhang Y, Qu M, Tang F, Han Y et al (2007) Association of DAOA polymorphisms with schizophrenia and clinical symptoms or therapeutic effects. Neurosci Lett 416:96\u2013100","journal-title":"Neurosci Lett"},{"key":"9288_CR191","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s002130051058","volume":"145","author":"K Yui","year":"1999","unstructured":"Yui K, Goto K, Ikemoto S, Ishiguro T, Kamada Y (1999) Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis. Psychopharmacology 145:267\u2013272","journal-title":"Psychopharmacology"},{"key":"9288_CR192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb05178.x","volume":"914","author":"K Yui","year":"2000","unstructured":"Yui K, Ikemoto S, Ishiguro T, Goto K (2000) Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia. Ann N Y Acad Sci 914:1\u201312","journal-title":"Ann N Y Acad Sci"},{"key":"9288_CR193","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ajmg.b.30076","volume":"129B","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Yu X, Yuan Y, Ling Y, Ruan Y, Si T et al (2004) Positive association of the human frizzled 3 (FZD3) gene haplotype with schizophrenia in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 129B:16\u201319","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9288_CR194","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/10550490490436055","volume":"13","author":"JE Zweben","year":"2004","unstructured":"Zweben JE, Cohen JB, Christian D, Galloway GP, Salinardi M, Parent D et al (2004) Psychiatric symptoms in methamphetamine users. Am J Addict 13:181\u2013190","journal-title":"Am J Addict"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11481-011-9288-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:52:10Z","timestamp":1741301530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-011-9288-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,5]]},"references-count":194,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9288"],"URL":"https:\/\/doi.org\/10.1007\/s11481-011-9288-1","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,5]]}}}